GS Acquisition Holdings Corp. II (GSAH.U), announced the pricing of their $700 million SPAC IPO this morning and the units are expected to begin trading today, Tuesday, June 30th, under the symbol NYSE: GSAH.U.
GS Acquisition Holdings II, is sponsored by GS Sponsor II LLC, an affiliate of The Goldman Sachs Group, Inc. GSAH II has a broad mandate to seek a target in any industry and will be led by Tom Knott, as Chief Executive Offer. Mr. Knott is a Managing Director at Goldman Sachs and is Head of GSAM’s Permanent Capital Strategies team. He is joined by Raanan A. Agus as Chairman. Mr. Agus is the Global Co-Head and Co-Chief Investment Officer of the AIMS group in GSAM.
Total SPAC deal count for 2020 year-to-date is now 36 with $11.7 billion in gross proceeds raised. The offering is anticipated to close on Wednesday, July 1, 2020.
Goldman Sachs & Co. LLC and Citigroup Global Markets Inc. are acting as joint book-running managers for the offering. Skadden, Arps, Slate, Meagher & Flom LLP and Ropes & Gray LLP, acted as Issuer’s Counsel and Underwriter’s Counsel, respectively. PricewaterhouseCoopers LLP acted as auditor.
AGBA (NASDAQ:AGBA) stock is up over +90% this morning following a +211% premarket spike on news it has signed a definitive agreement to combine with social streaming video platform Triller. AGBA, the company itself, was formed by the $555 million combination between a SPAC of the same name and TAG Companies, a financial services firm...
At the SPAC of Dawn Since closing its combination with DHC last month, AI customer engagement firm BEN (NASDAQ:BNAI) has rolled out new partnerships with call center and healthcare clients. And, while it faces a fair bit of competition in the chatbot realm, several high-profile institutions have demonstrated that creating one that provides useful services...
Blue Ocean (NASDAQ:BOCN) provided significantly more texture today in the presentation for its $275 million combination with Asian digital media group TNL Mediagene, which it expects to hit profitability in the second half of the year despite a slight shakeup in financing for the transaction. The first big update in the first investor deck is...
At the SPAC of Dawn A brand new market may have just opened up for space de-SPACs as NASA administrator Bill Nelson announced a shift in the agency’s $11 billion program for a mission to return samples from Mars. Rather than rely on the agency’s internal technologies that would be predicted to get a sample...
Overall deal flow between SPACs and biotech firms has slowed over the last year, but some pending FDA changes could breathe new life into particular business models within the space. In particular, the FDA has asked Congress as part of its 2025 Legislative Proposals to eliminate the interchangeability designation for biosimilar medications, claiming the existing...